T 1411/23 (Regimen for HDM2-p53 interaction inhibitors / NOVARTIS) of 13.05.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T141123.20250513
- Date of decision
- 13 May 2025
- Case number
- T 1411/23
- Online on
- 10 July 2025
- Petition for review of
- -
- Application number
- 17804304.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- DOSE AND REGIMEN FOR HDM2-P53 INTERACTION INHIBITORS
- Applicant name
- Novartis AG
- Opponent name
- STRAWMAN LIMITED
BOEHRINGER INGELHEIM INTERNATIONAL GMBH - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Late-filed evidence - admittance of documents filed in appeal proceedings
Inventive step - main request and auxiliary requests 1 to 7 (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.